About: John R. Mascola

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: John R. Mascola Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
owl:sameAs	John R. Mascola
description	researcher (en) 研究者 (ja) investigador (es) wetenschapper (nl) дослідник (uk) वैज्ञानिक (hi) изилдөөчү (ky) 研究者 (zh)
rdfs:label	John R Mascola (es) John R Mascola (nl) John R Mascola (ast) John R. Mascola (en)
skos:prefLabel	John R Mascola (es) John R Mascola (nl) John R Mascola (ast) John R. Mascola (en)
name	John R Mascola (es) John R Mascola (nl) John R Mascola (ast) John R. Mascola (en)
given name	wds:Q63302442-6447D53E-47F8-49D1-9492-DBCD31E58984
given name	John
instance of	wds:Q63302442-5DD8E82F-98B1-4239-A530-2FAD6A32D084
instance of	Homo sapiens
Google Knowledge Graph ID	wds:Q63302442-781C4656-7750-4091-BF14-3EAD3F40B6D2
Google Knowledge Graph ID	http://g.co/kg/g/11f010036h
Google Knowledge Graph ID	/g/11f010036h
Commons category	wds:Q63302442-99010b91-68f5-41ee-8859-67fc4a6fb7e4
Commons category	John Mascola
skos:altLabel	J R Mascola (en) J. R. Mascola (en) J.R. Mascola (en) JR Mascola (en) John Mascola (en) John R Mascola (en)
occupation	wds:Q63302442-826800E9-A5AB-475E-8076-706F5425C1EB
sex or gender	wds:Q63302442-d9ad9457-462e-0084-24e1-7dbb917b0bb8
VIAF ID	wds:Q63302442-fb89984e-4746-ce60-e8fd-2b88e0c06e39
Library of Congress authority ID	wds:Q63302442-3b3522f5-4b31-7b45-8504-235b69717b66
DBLP author ID	wds:Q63302442-16F35E07-0187-4289-AB45-37B7B3B224E9
VIAF ID	http://viaf.org/viaf/18148704203036931816
Library of Congress authority ID	http://id.loc.gov/authorities/names/n2017181140
DBLP author ID	https://dblp.org/pid/196/5722.rdf
occupation	researcher
sex or gender	male
VIAF ID	18148704203036931816
Library of Congress authority ID	n2017181140
DBLP author ID	196/5722
ORCID iD	wds:Q63302442-5C5B7A0B-08A7-48A1-BEF0-AEC240CE643D
ORCID iD	https://orcid.org/0000-0002-5293-4695
ORCID iD	0000-0002-5293-4695
is owl:sameAs of	John R. Mascola
is about of	John R. Mascola https://www.wikidata.org/wiki/Special:EntityData/Q63302442 John R. Mascola Category:John Mascola
is author of	Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype Neutralization of HIV-1 Infection of Human Peripheral Blood Mononuclear Cells (PBMC) : Infectivity Reduction Method A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay Genetic, antigenic and serologic characterization of human immunodeficiency virus type 1 from Indonesia Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults Structure-based identification and neutralization mechanism of tyrosine sulfate mimetics that inhibit HIV-1 entry Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort Immunoprophylaxis to prevent mother-to-child transmission of HIV-1. Human skin Langerhans cells are targets of dengue virus infection Human dendritic cells as targets of dengue virus infection Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells Evaluation of candidate vaccine approaches for MERS-CoV. Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs A short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodies Somatic Populations of PGT135-137 HIV-1-Neutralizing Antibodies Identified by 454 Pyrosequencing and Bioinformatics Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains Isolation of human monoclonal antibodies from peripheral blood B cells Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype Antibodies VRC01 and 10E8 neutralize HIV-1 with high breadth and potency even with Ig-framework regions substantially reverted to germline Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4. Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in nonhuman primates A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais Structural Basis for HIV-1 Neutralization by 2F5-Like Antibodies m66 and m66.6

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software